Sankey It
Loading...
Eli Lilly and Company Q4 FY2025 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company Q4 FY2025 income statement
USD · quarter ended 2025-12-31
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company Q4 FY2025 income statement
Flow diagram with 8 nodes and 7 flows for Eli Lilly and Company Q4 FY2025 income statement. Values: Revenue US$19.3B, Cost of Revenue US$2.9B, Gross Profit US$16.4B, Operating Expenses US$7.6B, Operating Income US$8.8B, Other Expense US$509.2M, Tax US$1.6B, Net Income US$6.6B.
Revenue
US$19.3B
Cost of Revenue
(US$2.9B)
15% of revenue
Gross Profit
US$16.4B
85% margin
Operating Expenses
(US$7.6B)
40% of revenue
Operating Income
US$8.8B
45% margin
Other Expense
(US$509.2M)
3% of revenue
Tax
(US$1.6B)
8% of revenue
Net Income
US$6.6B
34% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen